Morgan Stanley Investment Company Regulatory Fee Waived increased by 21.4% to $34.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 13.3%, from $30.00M to $34.00M. Over 4 years (FY 2021 to FY 2025), Investment Company Regulatory Fee Waived shows a downward trend with a -31.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
A decrease in fee waivers is generally positive for revenue, while an increase may signal a strategic decision to support fund performance or respond to competitive pricing pressures.
This metric quantifies the value of regulatory or management fees that the firm has voluntarily waived for investment co...
Commonly disclosed by asset managers and investment banks as 'Fee Waivers' or 'Management Fee Concessions'.
ms_investment_company_regulatory_fee_waived| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $131.00M | $139.00M | $152.00M | $124.00M | $41.00M | $28.00M | $18.00M | $18.00M | $28.00M | $27.00M | $20.00M | $24.00M | $25.00M | $25.00M | $25.00M | $30.00M | $30.00M | $29.00M | $28.00M | $34.00M |
| QoQ Change | — | +6.1% | +9.4% | -18.4% | -66.9% | -31.7% | -35.7% | +0.0% | +55.6% | -3.6% | -25.9% | +20.0% | +4.2% | +0.0% | +0.0% | +20.0% | +0.0% | -3.3% | -3.4% | +21.4% |
| YoY Change | — | — | — | — | -68.7% | -79.9% | -88.2% | -85.5% | -31.7% | -3.6% | +11.1% | +33.3% | -10.7% | -7.4% | +25.0% | +25.0% | +20.0% | +16.0% | +12.0% | +13.3% |